ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,145Medicare Part D Prescriptions Filled, Including Refills

Rank: 113 out of 1278

$461K Total Retail Price of All Prescriptions

Rank: 149 out of 1278

320 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
77% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 320 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 320 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 6,785 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LISINOPRIL 671 524 1 1
HYDROCHLOROTHIAZIDE 610 555 2 8
METFORMIN HCL 555 435 3 4
PRAVASTATIN SODIUM 451 359 4 14
TRAMADOL HCL 295 229 5 25
ALENDRONATE SODIUM 259 199 6 18
LEVOTHYROXINE SODIUM 258 164 7 2
PROAIR HFA 248 182 8 26
LOVASTATIN 238 205 9 13
ATENOLOL 238 161 9 11
LANTUS 225 126 11 33
OMEPRAZOLE 206 129 12 6
GLIMEPIRIDE 202 147 13 61
RANITIDINE HCL 176 145 14 20
ADVAIR DISKUS 173 107 15 49
SIMVASTATIN 163 105 16 3
ACTOS 135 115 17 72
FLUTICASONE PROPIONATE 135 90 17 24
SPIRIVA 133 110 19 65
GABAPENTIN 122 84 20 12
INSULIN SYRINGE 121 65 21 50
METOPROLOL TARTRATE 111 69 22 9
DOXAZOSIN MESYLATE 107 79 23 69
FUROSEMIDE 105 85 24 10
ATROVENT HFA 105 100 24 201
AMLODIPINE BESYLATE 105 74 24 5
TAMSULOSIN HCL 103 82 27 32
ATORVASTATIN CALCIUM 78 47 28 15
HYDROCODONE-ACETAMINOPHEN 76 60 S3 29 7
NIASPAN 72 54 30 131
GEMFIBROZIL 68 52 31 54
CYCLOBENZAPRINE HCL 56 29 R 32 62
HYDROXYZINE HCL 54 24 R 33 151
ALLOPURINOL 53 51 34 36
NOVOLOG 52 31 35 118
PIOGLITAZONE HCL 52 46 R 35 188
FENOFIBRATE 51 37 37 47
VERAPAMIL ER 50 50 38 84
DIOVAN 50 50 38 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.